Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.

Rheumatology (Oxford, England)

Volumn 49, Issue 1, 2010, Pages 173-177

  Hamuryudan, Vedat ^a   Hatemi, Gulen ^b   Tascilar, Koray ^b   Sut, Necdet ^b   Ozyazgan, Yilmaz ^b   Seyahi, Emire ^b   Mat, Cem ^b   Yurdakul, Sebahattin ^b   Yazici, Hasan ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; IMMUNOSUPPRESSIVE AGENT; THALIDOMIDE;

ADOLESCENT; ADULT; AGE; ARTICLE; BEHCET DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG UTILIZATION; FOLLOW UP; HUMAN; MALE; MOUTH ULCER; ONSET AGE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICS; TREATMENT OUTCOME; UVEITIS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; BEHCET SYNDROME; COLCHICINE; DRUG UTILIZATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; ORAL ULCER; PROGNOSIS; THALIDOMIDE; TREATMENT OUTCOME; UVEITIS; YOUNG ADULT;

EID: 78049491130     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep350     Document Type: Article

References (0)